Brian Lenz
2012 - ADMA Biologics
In 2012, Brian Lenz earned a total compensation of $695.8K as Chief Financial Officer at ADMA Biologics.
Compensation breakdown
| Bonus | $77,250 |
|---|---|
| Option Awards | $450,200 |
| Salary | $168,365 |
| Total | $695,815 |
Lenz received $450.2K in option awards, accounting for 65% of the total pay in 2012.
Lenz also received $77.3K in bonus and $168.4K in salary.
Rankings
In 2012, Brian Lenz's compensation ranked 7,590th out of 11,487 executives tracked by ExecPay. In other words, Lenz earned more than 33.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,590 out of 11,487 | 34th |
Division Manufacturing | 2,733 out of 4,253 | 36th |
Major group Chemicals And Allied Products | 710 out of 1,198 | 41st |
Industry group Drugs | 499 out of 920 | 46th |
Industry Biological Products, Except Diagnostic Substances | 79 out of 160 | 51st |
Source: SEC filing on April 29, 2014.
Lenz's colleagues
We found two more compensation records of executives who worked with Brian Lenz at ADMA Biologics in 2012.
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019